Corticosteroid Use in Specific Lower Respiratory Infections

Evidence for Corticosteroid Use in Certain Conditions

The American Thoracic Society and European Respiratory Society guidelines suggest that corticosteroids have proven benefit in specific conditions, such as severe community-acquired pneumonia, where low-dose corticosteroids reduce 30-day mortality, although the exact mortality reduction is not specified in the provided text 1, 2, 3
The European Respiratory Journal recommends considering undiagnosed asthma or COPD in patients with lower respiratory infections, as these conditions may benefit from corticosteroid therapy, with a focus on symptomatic management and appropriate antibiotic use 4, 5
The Clinical Microbiology and Infection journal suggests that patient education about expected illness duration is crucial in managing uncomplicated lower respiratory tract infections, and that prescribing prednisone offers no benefit in these cases 4, 6

The European Respiratory Journal guidelines recommend ensuring the patient truly lacks undiagnosed asthma or COPD before reconsidering the diagnosis, as these conditions may benefit from corticosteroid therapy 4, 5
The Clinical Microbiology and Infection journal suggests considering severe pneumonia requiring ICU-level care, specific infections where corticosteroids have proven benefit, and patient education about expected illness duration in managing lower respiratory infections 4, 6

Obtain chest imaging, pulse oximetry, and consider infectious workup including sputum culture if productive cough present in patients with pleural parenchymal opacities and wheezing 7
For COPD exacerbation with significant breathlessness, prednisone 30-40 mg daily for 5 days is recommended by the European Respiratory Society 8, 9

If allergic bronchopulmonary aspergillosis (ABPA) is suspected, look for episodic wheezing, peripheral eosinophilia, history of asthma, and brown sputum plugs, and treat with prednisone 0.5 mg/kg/day for 2 weeks with monitoring of total IgE levels 10, 11, 12
The British Thoracic Society recommends specific immunologic testing (Aspergillus-specific IgE, precipitating antibodies) for confirmation of ABPA 10, 11, 12

For post-infectious cough lasting less than 3 weeks, consider ipratropium instead of steroids 13
The European Respiratory Society and American Thoracic Society guidelines state that corticosteroids in lower respiratory infections require confirmed asthma or COPD to be beneficial, and bacterial pneumonia should only be treated with steroids if meeting severe community-acquired pneumonia criteria requiring ICU care 8, 9, 14